Last reviewed · How we verify

sham oxygen (room air)

University of Zurich · FDA-approved active Small molecule

sham oxygen (room air) is a Small molecule drug developed by University of Zurich. It is currently FDA-approved for Placebo control in oxygen therapy trials. Also known as: Nocturnal nasal room air during stay at 2048 m, Nocturnal nasal room air administration.

Sham oxygen (room air) serves as a placebo control in clinical trials, delivering ambient air without supplemental oxygen to assess the true therapeutic effect of oxygen therapy.

Sham oxygen (room air) serves as a placebo control in clinical trials, delivering ambient air without supplemental oxygen to assess the true therapeutic effect of oxygen therapy. Used for Placebo control in oxygen therapy trials.

At a glance

Generic namesham oxygen (room air)
Also known asNocturnal nasal room air during stay at 2048 m, Nocturnal nasal room air administration
SponsorUniversity of Zurich
ModalitySmall molecule
Therapeutic areaClinical Research / Methodology
PhaseFDA-approved

Mechanism of action

Sham oxygen is not a therapeutic agent but rather a control intervention used in blinded clinical trials to evaluate the efficacy of actual oxygen therapy. By administering room air (approximately 21% oxygen) in a manner identical to active oxygen treatment, researchers can isolate the placebo effect and determine whether observed clinical benefits are attributable to supplemental oxygen or to other factors such as patient expectation and study design.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about sham oxygen (room air)

What is sham oxygen (room air)?

sham oxygen (room air) is a Small molecule drug developed by University of Zurich, indicated for Placebo control in oxygen therapy trials.

How does sham oxygen (room air) work?

Sham oxygen (room air) serves as a placebo control in clinical trials, delivering ambient air without supplemental oxygen to assess the true therapeutic effect of oxygen therapy.

What is sham oxygen (room air) used for?

sham oxygen (room air) is indicated for Placebo control in oxygen therapy trials.

Who makes sham oxygen (room air)?

sham oxygen (room air) is developed and marketed by University of Zurich (see full University of Zurich pipeline at /company/university-of-zurich).

Is sham oxygen (room air) also known as anything else?

sham oxygen (room air) is also known as Nocturnal nasal room air during stay at 2048 m, Nocturnal nasal room air administration.

What development phase is sham oxygen (room air) in?

sham oxygen (room air) is FDA-approved (marketed).

Related